Australia Irritable Bowel Syndrome (IBS) Market (2025-2031) | Trends, Outlook, Segmentation, Size & Revenue, Growth, Companies, Analysis, Competitive Landscape, Industry, Forecast, Value, Share

Market Forecast By Drug Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Others), By Medical Condition (IBS-Constipation, IBS-diarrhea, Mixed), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By End-Users (Hospitals, Clinics, Homecare Settings) And Competitive Landscape
Product Code: ETC6183360 Publication Date: Sep 2024 Updated Date: Apr 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Vasudha No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Australia Irritable Bowel Syndrome Ibs Market Overview

The IBS market in Australia is expanding due to the rising prevalence of gastrointestinal disorders and increasing awareness of digestive health. Diagnosis rates have improved due to better diagnostic tools and growing awareness among the general population. Treatments include a combination of dietary management, lifestyle changes, and medications such as antispasmodics and laxatives. The market is characterized by a growing interest in probiotics, natural remedies, and gut health solutions, driven by consumer preferences for holistic wellness approaches.

Trends of the market

The IBS market in Australia is showing a rising trend due to growing public awareness of gastrointestinal health and an increase in the diagnosed cases of IBS. Consumers are turning to both conventional pharmaceuticals and natural or probiotic-based therapies. Lifestyle and dietary management solutions are also becoming increasingly popular. The market is further supported by increased funding in digestive health research and the broader acceptance of gut health as a key component of overall wellness.

Challenges of the market

In the Australia irritable bowel syndrome (IBS) market, challenges arise from the complexity of accurately diagnosing IBS, given its overlapping symptoms with other gastrointestinal disorders. Limited effective treatment options and the high variability of individual patient responses to therapies also constrain market growth.

Investment opportunities in the Market

Investors in the IBS market can leverage the increasing prevalence of gastrointestinal disorders linked to lifestyle, stress, and dietary changes. There`s a rising demand for personalized treatment solutions, probiotic formulations, and gut health supplements. Opportunities exist in diagnostics, functional foods, and telemedicine services tailored for IBS management. Moreover, growing awareness and destigmatization of digestive health issues open doors for consumer education and digital health platforms.

Government Policy of the market

The Australian government`s focus on gut health research funding through institutions like the NHMRC (National Health and Medical Research Council) benefits the IBS market. Policies promoting dietary education and the regulation of pharmaceutical treatments for IBS also play a critical role.

Key Highlights of the Report:

  • Australia Irritable Bowel Syndrome (IBS) Market Outlook
  • Market Size of Australia Irritable Bowel Syndrome (IBS) Market, 2024
  • Forecast of Australia Irritable Bowel Syndrome (IBS) Market, 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Revenues & Volume for the Period 2021- 2031
  • Australia Irritable Bowel Syndrome (IBS) Market Trend Evolution
  • Australia Irritable Bowel Syndrome (IBS) Market Drivers and Challenges
  • Australia Irritable Bowel Syndrome (IBS) Price Trends
  • Australia Irritable Bowel Syndrome (IBS) Porter's Five Forces
  • Australia Irritable Bowel Syndrome (IBS) Industry Life Cycle
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Drug Type for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Lubiprostone for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Linaclotide for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Eluxadoline for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Rifaximin for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Alosetron for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Medical Condition for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By IBS-Constipation for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By IBS-diarrhea for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Mixed for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Online Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Retail Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By End-Users for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Clinics for the Period 2021- 2031
  • Historical Data and Forecast of Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume By Homecare Settings for the Period 2021- 2031
  • Australia Irritable Bowel Syndrome (IBS) Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Type
  • Market Opportunity Assessment By Medical Condition
  • Market Opportunity Assessment By Distribution Channel
  • Market Opportunity Assessment By End-Users
  • Australia Irritable Bowel Syndrome (IBS) Top Companies Market Share
  • Australia Irritable Bowel Syndrome (IBS) Competitive Benchmarking By Technical and Operational Parameters
  • Australia Irritable Bowel Syndrome (IBS) Company Profiles
  • Australia Irritable Bowel Syndrome (IBS) Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 Australia Irritable Bowel Syndrome (IBS) Market Overview

3.1 Australia Country Macro Economic Indicators

3.2 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, 2021 & 2031F

3.3 Australia Irritable Bowel Syndrome (IBS) Market - Industry Life Cycle

3.4 Australia Irritable Bowel Syndrome (IBS) Market - Porter's Five Forces

3.5 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

3.6 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Medical Condition, 2021 & 2031F

3.7 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

3.8 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By End-Users, 2021 & 2031F

4 Australia Irritable Bowel Syndrome (IBS) Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 Australia Irritable Bowel Syndrome (IBS) Market Trends

6 Australia Irritable Bowel Syndrome (IBS) Market, By Types

6.1 Australia Irritable Bowel Syndrome (IBS) Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Lubiprostone, 2021- 2031F

6.1.4 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Linaclotide, 2021- 2031F

6.1.5 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Eluxadoline, 2021- 2031F

6.1.6 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Rifaximin, 2021- 2031F

6.1.7 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Alosetron, 2021- 2031F

6.1.8 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Others, 2021- 2031F

6.2 Australia Irritable Bowel Syndrome (IBS) Market, By Medical Condition

6.2.1 Overview and Analysis

6.2.2 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-Constipation, 2021- 2031F

6.2.3 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-diarrhea, 2021- 2031F

6.2.4 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Mixed, 2021- 2031F

6.3 Australia Irritable Bowel Syndrome (IBS) Market, By Distribution Channel

6.3.1 Overview and Analysis

6.3.2 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.3.3 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

6.3.4 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4 Australia Irritable Bowel Syndrome (IBS) Market, By End-Users

6.4.1 Overview and Analysis

6.4.2 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospitals, 2021- 2031F

6.4.3 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 Australia Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Homecare Settings, 2021- 2031F

7 Australia Irritable Bowel Syndrome (IBS) Market Import-Export Trade Statistics

7.1 Australia Irritable Bowel Syndrome (IBS) Market Export to Major Countries

7.2 Australia Irritable Bowel Syndrome (IBS) Market Imports from Major Countries

8 Australia Irritable Bowel Syndrome (IBS) Market Key Performance Indicators

9 Australia Irritable Bowel Syndrome (IBS) Market - Opportunity Assessment

9.1 Australia Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Drug Type, 2021 & 2031F

9.2 Australia Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Medical Condition, 2021 & 2031F

9.3 Australia Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

9.4 Australia Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By End-Users, 2021 & 2031F

10 Australia Irritable Bowel Syndrome (IBS) Market - Competitive Landscape

10.1 Australia Irritable Bowel Syndrome (IBS) Market Revenue Share, By Companies, 2024

10.2 Australia Irritable Bowel Syndrome (IBS) Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All